Kava and kratom are both legal botanical products with anxiety-reducing and relaxing effects, but they work through completely different mechanisms and carry different risk profiles. Kava acts primarily on GABA-A receptors through kavalactones, producing calm and muscle relaxation without psychoactive stimulation. Kratom activates opioid receptors through mitragynine and 7-hydroxymitragynine, producing stimulant effects at low doses and sedative/analgesic effects at high doses. They are not interchangeable: kava is non-stimulating; kratom is dose-dependently stimulant then sedating. Combining them is increasingly common but requires understanding both mechanisms.

How do the active compounds differ?

Kava's active compounds are kavalactones — a class of lactone compounds that bind GABA-A receptors and block sodium/calcium channels. There is no opioid receptor activity. Kratom's primary compounds are indole alkaloids: mitragynine (partial mu-opioid agonist at high concentrations, adrenergic agonist at low concentrations) and 7-hydroxymitragynine (full mu-opioid agonist, estimated 13× more potent than morphine). The practical difference: kava's mechanism has no addiction potential comparable to opioid receptor activity; kratom, particularly concentrated 7-OH extracts, carries real opioid-class dependency risk with regular heavy use.

Which one is better for anxiety?

For anxiety specifically, kava has stronger clinical evidence. Multiple randomized controlled trials support kava's anxiolytic effects, including a 2013 trial in Journal of Clinical Psychopharmacology showing significant HAM-A score reduction at 300mg kavalactones/day. Kratom has limited formal clinical research for anxiety. Users report that kratom at low doses (2–4g) reduces social anxiety through adrenergic modulation, but the dose window for anxiety relief versus sedation is narrow and tolerance builds faster than with kava. For anyone primarily seeking anxiety relief, kava is the better-evidenced starting point.

Which is better for energy?

Kratom wins on energy — kava does not produce stimulant effects. At 1–3g, kratom powder produces a coffee-like energy and focus boost through adrenergic activity. Kava, even at low doses, produces relaxation, not stimulation. If energy and focus are the goal, kratom is the appropriate choice. Rave Kratom Boost products at elevatedhaze.com are formulated specifically for energy effects, using 7-OH-free extracts to provide the stimulant benefits without opioid-level intensity. Kava and kratom are sometimes combined — kratom for energy, kava for the relaxation endpoint — but this requires careful dosing.

Which has higher dependency risk?

Kratom carries higher dependency risk, particularly with regular use of high doses or concentrated extracts. The opioid receptor activity of 7-OH creates tolerance and physical dependence similar to opioid drugs. A 2019 survey in Drug and Alcohol Dependence found withdrawal symptoms in users taking 5+ grams more than 3 times weekly. Kava dependency at typical doses is much milder — most clinical and traditional use data does not show severe physical withdrawal. Dermopathy (skin scaling) with excessive kava use is reversible and not an addiction symptom. For anyone with opioid sensitivity or history, kava is the safer choice.

Can you take kava and kratom together?

Some users combine kava and kratom, and Rave Kratom's NUMB formula at elevatedhaze.com actually includes both in a single product. The combination is reported to produce: kratom's energy/mood lift from low-dose mitragynine activity, plus kava's muscle relaxation and anxiety reduction from kavalactones — with less sedation than high-dose kratom alone. That said, combining two CNS-active botanicals requires extra attention to individual tolerance and starting with low doses of each. Don't combine either with alcohol, benzodiazepines, or other opioid medications.